TY - JOUR
T1 - HMGB1 and leukocyte migration during trauma and sterile inflammation
AU - Venereau, Emilie
AU - Schiraldi, Milena
AU - Uguccioni, Mariagrazia
AU - Bianchi, Marco E.
PY - 2013/8
Y1 - 2013/8
N2 - HMGB1 is a nuclear protein that is released or secreted following trauma or severe cellular stress. Extracellular HMGB1 triggers inflammation and recruits leukocytes to the site of tissue damage. We review recent evidence that the ability of HMGB1 to recruit leukocytes may be entirely due to the formation of a heterocomplex with the homeostatic chemokine CXCL12. The HMGB1-CXCL12 heterocomplex acts on the CXCR4 receptor more potently than CXCL12 alone. Notably, only one of the redox forms of HMGB1, the one where all cysteines are reduced (all-thiol), can bind CXCL12. Both HMGB1 containing a disulfide bond between C23 and C45, which induces chemokine and cytokine release by activating TLR4, and HMGB1 terminally oxidized to contain a cysteine sulfonate are inactive in recruiting leukocytes. Thus, the chemoattractant and cytokine-inducing activities of HMGB1 are separable, and we propose that they appear sequentially during the development of inflammation and its resolution. The HMGB1-CXCL12 heterocomplex constitutes a specific target that may hold promise for the treatment of several pathologies.
AB - HMGB1 is a nuclear protein that is released or secreted following trauma or severe cellular stress. Extracellular HMGB1 triggers inflammation and recruits leukocytes to the site of tissue damage. We review recent evidence that the ability of HMGB1 to recruit leukocytes may be entirely due to the formation of a heterocomplex with the homeostatic chemokine CXCL12. The HMGB1-CXCL12 heterocomplex acts on the CXCR4 receptor more potently than CXCL12 alone. Notably, only one of the redox forms of HMGB1, the one where all cysteines are reduced (all-thiol), can bind CXCL12. Both HMGB1 containing a disulfide bond between C23 and C45, which induces chemokine and cytokine release by activating TLR4, and HMGB1 terminally oxidized to contain a cysteine sulfonate are inactive in recruiting leukocytes. Thus, the chemoattractant and cytokine-inducing activities of HMGB1 are separable, and we propose that they appear sequentially during the development of inflammation and its resolution. The HMGB1-CXCL12 heterocomplex constitutes a specific target that may hold promise for the treatment of several pathologies.
KW - Chemokine
KW - CXCL12
KW - CXCR4
KW - Oxidation
KW - RAGE
KW - TLR4
UR - http://www.scopus.com/inward/record.url?scp=84875631644&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875631644&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2012.10.037
DO - 10.1016/j.molimm.2012.10.037
M3 - Article
C2 - 23207101
AN - SCOPUS:84875631644
VL - 55
SP - 76
EP - 82
JO - Molecular Immunology
JF - Molecular Immunology
SN - 0161-5890
IS - 1
ER -